Join
Live feed
·
INSIDERFilingvia Quantisnow
Ligand Pharmaceuticals Incorporated logo

CLO & Secretary Reardon Andrew sold $1,430,434 worth of shares (5,000 units at $286.09) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 36,514 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.